Overview · Filed: —
UPC_APP_16366/2025
RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
Procedural & sub-applicationsWithdrawal ApplicationsMilan CDApplication Rop 265—Settled at: Pre-merits
Parties
Claimants
- Pfizer, Inc.
- Pfizer Europe MA EEIG
- Pfizer B.V.
- Pfizer S.A.
- Pfizer Manufacturing Belgium S.A.
- Pfizer Service Company S.R.L.
- Pfizer Pharma GmbH
- Pfizer Limited
- Pfizer Corporation Austria GmbH
- Pfizer Aps
- Pfizer Oy
- Pfizer SAS
- Pfizer S.r.l.
- Laboratórios Pfizer, Lda.
- Pfizer AB
- Pfizer Luxembourg S.a.r.l.
Reps: Gareth Williams
Respondents
- GlaxoSmithKline Biologicals SA
Reps: Oliver Jan Juengst; Daniela Kinkeldey
Judges
- Andrea PostiglionePresiding Judge
- Anna-Lena KleinJudge-Rapporteur
- Steen Lyders Wadskov-HansenTechnically Qualified Judge
Patents
- EP 4183412
CPC codes: C12N2760/18522, C12N2760/18534, A61K2039/55505, A61K2039/5258, A61K2039/55566, A61K39/155, A61K39/12, C07K2319/73, A61K2039/53, C07K2317/76, A61P31/14, A61P37/04…
Sector: Biotechnology
Outcome
Withdrawn
Filed: —
First decided: Apr 22, 2025
Language: —
Settled at: Pre-merits
Milan Central Division procedural order granting Pfizer's application to withdraw a revocation action against GlaxoSmithKline Biologicals SA concerning EP 4 183 412 (RSV F protein vaccine patent), and a separately filed counterclaim for revocation in parallel Düsseldorf infringement proceedings (which had been referred to the Central Division). Pfizer and Glaxo had each filed applications to amend the patent; both revocation actions were withdrawn by Pfizer prior to closure of the written procedure. The court also ordered 60% reimbursement of court fees and confirmed each party bears its own costs.